These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 22917141)

  • 1. Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges.
    Bartlett JW; Frost C; Mattsson N; Skillbäck T; Blennow K; Zetterberg H; Schott JM
    Biomark Med; 2012 Aug; 6(4):391-400. PubMed ID: 22917141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analytical aspects of molecular Alzheimer's disease biomarkers.
    Andreasson U; Vanmechelen E; Shaw LM; Zetterberg H; Vanderstichele H
    Biomark Med; 2012 Aug; 6(4):377-89. PubMed ID: 22917140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reference measurement procedures for Alzheimer's disease cerebrospinal fluid biomarkers: definitions and approaches with focus on amyloid β42.
    Mattsson N; Zegers I; Andreasson U; Bjerke M; Blankenstein MA; Bowser R; Carrillo MC; Gobom J; Heath T; Jenkins R; Jeromin A; Kaplow J; Kidd D; Laterza OF; Lockhart A; Lunn MP; Martone RL; Mills K; Pannee J; Ratcliffe M; Shaw LM; Simon AJ; Soares H; Teunissen CE; Verbeek MM; Umek RM; Vanderstichele H; Zetterberg H; Blennow K; Portelius E
    Biomark Med; 2012 Aug; 6(4):409-17. PubMed ID: 22917143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proficiency testing programs for Alzheimer's disease cerebrospinal fluid biomarkers.
    Mattsson N; Andreasson U; Carrillo MC; Persson S; Shaw LM; Zegers I; Zetterberg H; Blennow K
    Biomark Med; 2012 Aug; 6(4):401-7. PubMed ID: 22917142
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [A new approach to the Alzheimer's disease diagnosis with biomarkers: description of the AD-CSF-Index].
    Molinuevo JL; Gispert JD; Pujol J; Rojas S; Lladó A; Balasa M; Antonell A; Sánchez-Valle R; Rami L
    Rev Neurol; 2012 May; 54(9):513-22. PubMed ID: 22532214
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Biomarkers for Alzheimer's disease: after Alzheimer's disease neuroimaging initiative studies].
    Shoji M
    Brain Nerve; 2012 May; 64(5):497-504. PubMed ID: 22570063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical use of cerebrospinal fluid biomarkers in Alzheimer's disease.
    Zetterberg H; Lunn MP; Herukka SK
    Biomark Med; 2012 Aug; 6(4):371-6. PubMed ID: 22917139
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of two analytical platforms for the clinical qualification of Alzheimer's disease biomarkers in pathologically-confirmed dementia.
    Le Bastard N; Coart E; Vanderstichele H; Vanmechelen E; Martin JJ; Engelborghs S
    J Alzheimers Dis; 2013; 33(1):117-31. PubMed ID: 22936010
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of Alzheimer's disease CSF and plasma biological markers: the multicentre reliability study of the pilot European Alzheimer's Disease Neuroimaging Initiative (E-ADNI).
    Buerger K; Frisoni G; Uspenskaya O; Ewers M; Zetterberg H; Geroldi C; Binetti G; Johannsen P; Rossini PM; Wahlund LO; Vellas B; Blennow K; Hampel H
    Exp Gerontol; 2009 Sep; 44(9):579-85. PubMed ID: 19539742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New research criteria for the diagnosis of Alzheimer's disease applied in a memory clinic population.
    Bouwman FH; Verwey NA; Klein M; Kok A; Blankenstein MA; Sluimer JD; Barkhof F; van der Flier WM; Scheltens P
    Dement Geriatr Cogn Disord; 2010; 30(1):1-7. PubMed ID: 20606438
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebrospinal fluid biomarkers for Alzheimer's disease: more to come?
    Zetterberg H; Blennow K
    J Alzheimers Dis; 2013; 33 Suppl 1():S361-9. PubMed ID: 22710917
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decreased sAβPPβ, Aβ38, and Aβ40 cerebrospinal fluid levels in frontotemporal dementia.
    Gabelle A; Roche S; Gény C; Bennys K; Labauge P; Tholance Y; Quadrio I; Tiers L; Gor B; Boulanghien J; Chaulet C; Vighetto A; Croisile B; Krolak-Salmon P; Perret-Liaudet A; Touchon J; Lehmann S
    J Alzheimers Dis; 2011; 26(3):553-63. PubMed ID: 21709372
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Standardization of preanalytical aspects of cerebrospinal fluid biomarker testing for Alzheimer's disease diagnosis: a consensus paper from the Alzheimer's Biomarkers Standardization Initiative.
    Vanderstichele H; Bibl M; Engelborghs S; Le Bastard N; Lewczuk P; Molinuevo JL; Parnetti L; Perret-Liaudet A; Shaw LM; Teunissen C; Wouters D; Blennow K
    Alzheimers Dement; 2012 Jan; 8(1):65-73. PubMed ID: 22047631
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recommendations to standardize preanalytical confounding factors in Alzheimer's and Parkinson's disease cerebrospinal fluid biomarkers: an update.
    del Campo M; Mollenhauer B; Bertolotto A; Engelborghs S; Hampel H; Simonsen AH; Kapaki E; Kruse N; Le Bastard N; Lehmann S; Molinuevo JL; Parnetti L; Perret-Liaudet A; Sáez-Valero J; Saka E; Urbani A; Vanmechelen E; Verbeek M; Visser PJ; Teunissen C
    Biomark Med; 2012 Aug; 6(4):419-30. PubMed ID: 22917144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fluid biomarkers for Alzheimer's disease: standardization and recent developments.
    Zetterberg H; Visser PJ
    Biomark Med; 2012 Aug; 6(4):363-4. PubMed ID: 22917136
    [No Abstract]   [Full Text] [Related]  

  • 16. A screening UHPLC-MS/MS method for the analysis of amyloid peptides in cerebrospinal fluid of preclinical species.
    Dillen L; Cools W; Vereyken L; Timmerman P
    Bioanalysis; 2011 Jan; 3(1):45-55. PubMed ID: 21175366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CSF biomarkers for Alzheimer's Disease: levels of beta-amyloid, tau, phosphorylated tau relate to clinical symptoms and survival.
    Wallin AK; Blennow K; Andreasen N; Minthon L
    Dement Geriatr Cogn Disord; 2006; 21(3):131-8. PubMed ID: 16391474
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Biomarker of dementia: clinical and preclinical diagnosis].
    Shoji M
    Nihon Rinsho; 2012 May; 70(5):857-63. PubMed ID: 22620013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantifying the pathophysiological timeline of Alzheimer's disease.
    Yang E; Farnum M; Lobanov V; Schultz T; Verbeeck R; Raghavan N; Samtani MN; Novak G; Narayan V; DiBernardo A;
    J Alzheimers Dis; 2011; 26(4):745-53. PubMed ID: 21694449
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alzheimer's biomarker initiative hits its stride.
    Miller G
    Science; 2009 Oct; 326(5951):386-9. PubMed ID: 19833956
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.